Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, et al
Supplementary information Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
Subcutaneous injection is the standard administration route for MOTS-c due to poor oral bioavailability peptide bonds are rapidly degraded by gastrointestinal proteases, significantly reducing systemic absorption
We honor that paceyoure in control, not the clock